exp561 has been researched along with atomoxetine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, ND; Robertson, DW; Swartzendruber, JK; Wong, DT; Yang, KS | 1 |
| Hoffman, BT; Katz, JL; Kopajtic, T; Newman, AH | 1 |
2 other study(ies) available for exp561 and atomoxetine
| Article | Year |
|---|---|
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.
Topics: Animals; Brain; Fluoxetine; Kinetics; Models, Molecular; Molecular Conformation; Norepinephrine; Propylamines; Rats; Serotonin; Serotonin Antagonists; Synaptosomes; X-Ray Diffraction | 1988 |
2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Topics: Algorithms; Binding, Competitive; Carrier Proteins; Databases, Factual; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Models, Molecular; Nerve Tissue Proteins; Quantitative Structure-Activity Relationship; Radioligand Assay; Reproducibility of Results; Software | 2000 |